收稿日期: 2020-09-29
网络出版日期: 2022-06-28
基金资助
上海市医学重点专科-消化内科建设项目(ZK20194B18)
王虹 . 胃食管反流病的临床表现分类及精准治疗策略[J]. 诊断学理论与实践, 2021 , 20(03) : 251 -256 . DOI: 10.16150/j.1671-2870.2021.03.005
| [1] | Vakil N, van Zanten SV, et al. The montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus[J]. Am J Gastroenterol, 2006, 101(8):1900-1920. |
| [2] | Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification[J]. Gut, 1999, 45(2):172-180. |
| [3] | El-Serag HB, Graham DY, Satia JA, et al. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis[J]. Am J Gastroenterol, 2005, 100(6):1243-1250. |
| [4] | Savarino E, Tutuian R, Zentilin P, et al. Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy[J]. Am J Gastroenterol, 2010, 105(5):1053-1061. |
| [5] | Kasyap AK, Sah SK, Chaudhary S. Clinical spectrum and risk factors associated with asymptomatic erosive esophagitis as determined by Los Angeles classification: A cross-sectional study[J]. PLoS One, 2018, 13:e0192739. |
| [6] | Ronkainen J, Talley NJ, Storskrubb T, et al. Erosive esophagitis is a risk factor for Barrett′s esophagus: a community-based endoscopic follow-up study[J]. Am J Gastroenterol, 2011, 106(11):1946-1952. |
| [7] | Hsu PI, Lu CL, Wu DC, et al. Eight weeks of esomeprazole therapy reduces symptom relapse, compared with 4 weeks, in patients with Los Angeles grade A or B erosive esophagitis[J]. Clin Gastroenterol Hepatol, 2015, 13(5):859-866. |
| [8] | Takashima T, Iwakiri R, Sakata Y, et al. Endoscopic reflux esophagitis and Helicobacter pylori infection in young healthy Japanese volunteers[J]. Digestion, 2012, 86(1):55-58. |
| [9] | Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon Consensus[J]. Gut, 2018, 67(7):1351-1362. |
| [10] | Aziz Q, Fass R, Gyawali CP, et al. Esophageal disorders[J]. Gastroenterology 2016, 150(6):1368-1379. |
| [11] | Patel DA, Higginbotham T, Slaughter JC, et al. Development and validation of a mucosal impedance contour analysis system to distinguish esophageal disorders[J]. Gastroenterology, 2019, 156(6):1617-1626. |
| [12] | Woodland P, Shen Ooi JL, Grassi F, et al. Superficial esophageal mucosal afferent nerves may contribute to reflux hypersensitivity in nonerosive reflux disease[J]. Gastroenterology, 2017, 153(5):1230-1239. |
| [13] | Chua YC, Aziz Q. Perception of gastro-oesophageal reflux[J]. Best Pract Res Clin Gastroenterol, 2010, 24(6):883-891. |
| [14] | Willert RP, Delaney C, Kelly K, et al. Exploring the neurophysiological basis of chest wall allodynia induced by experimental oesophageal acidification - evidence of central sensitization[J]. Neurogastroenterol Motil, 2007, 19(4):270-278. |
| [15] | Coen SJ, Kano M, Farmer AD, et al. Neuroticism in fluences brain activity during the experience of visceral pain[J]. Gastroenterology, 2011, 141(3):909-917. |
| [16] | Katzka DA, Pandolfino JE, Kahrilas PJ. Phenotypes of gastroesophageal reflux disease: where Rome, Lyon, and Montreal Meet[J]. Clin Gastroenterol Hepatol, 2020, 18(4):767-776. |
| [17] | Kahrilas PJ, Howden CW, Wernersson B, et al. Impact of persistent, frequent regurgitation on quality of life in heartburn responders treated with acid suppression: a multinational primary care study[J]. Aliment Pharmacol Ther, 2013, 37(10):1005-1010. |
| [18] | Bell R, Lipham J, Louie B, et al. Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial[J]. Gastrointest Endosc, 2019, 89(1):14-22. |
| [19] | Absah I, Rishi A, Talley NJ, et al. Rumination syndrome:pathophysiology, diagnosis, and treatment[J]. Neurogastroenterol Motil, 2017, 29(4):12954. |
| [20] | Halland M, Parthasarathy G, Bharucha AE, et al. Dia-phragmatic breathing for rumination syndrome: efficacy and mechanisms of action[J]. Neurogastroenterol Motil, 2016, 28(3):384-391. |
| [21] | Pandolfino JE, Zhang QG, Ghosh SK, et al. Transientlower esophageal sphincter relaxations and reflux: mechanistic analysis using concurrent fluoroscopy and high-resolution manometry[J]. Gastroenterology, 2006, 131(6):1725-1733. |
| [22] | Pauwels A, Broers C, Van Houtte B, et al. A Randomized double-blind, placebo-controlled, cross-over study using baclofen in the treatment of rumination syndrome[J]. Am J Gastroenterol, 2018, 113(1):97-104. |
| [23] | Zerbib F, Roman S, Bruley Des Varannes S, et al. Normal values of pharyngeal and esophageal 24-hour pH impedance in individuals on and off therapy and interobserver reproducibility[J]. Clin Gastroenterol Hepatol, 2013, 11(4):366-372. |
| [24] | Woodland P, Singendonk MMJ, Ooi J, et al. Measurement of salivary pepsin to detect gastroesophageal reflux di-sease is not ready for clinical application[J]. Clin Gas-troenterol Hepatol, 2019, 17(3):563-565. |
| [25] | Vaezi MF, Richter JE, Stasney CR, et al. Treatment of chronic posterior laryngitis with esomeprazole[J]. Laryngoscope, 2006, 116(2):254-260. |
| [26] | Gyawali CP, Fass R. Management of gastroesophageal reflux disease[J]. Gastroenterology, 2018, 154(2):302-318. |
| [27] | Kahrilas PJ, Howden CW, Hughes N, et al. Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease[J]. Chest, 2013, 143(3):605-612. |
| [28] | Toros SZ, Toros AB, Yüksel OD, et al. Association of laryngopharyngeal manifestations and gastroesophageal reflux[J]. Eur Arch Otorhinolaryngol, 2009, 266(3):403-409. |
| [29] | Gomez Cifuentes J, Lopez R, et al. Factors predictive of gastroesophageal reflux disease and esophageal motility disorders in patients with non-cardiac chest pain[J]. Scand J Gastroenterol, 2018, 53(6):643-649. |
| [30] | Herregods TVK, Bredenoord AJ, Oors JM, et al. Determinants of the association between non-cardiac chest pain and reflux[J]. Am J Gastroenterol, 2017, 112(11):1671-1677. |
| [31] | Sarkar S, Thompson DG, Woolf CJ, et al. Patients with chest pain and occult gastroesophageal reflux demonstrate visceral pain hypersensitivity which may be partially responsive to acid suppression[J]. Am J Gastroenterol, 2004, 99(10):1998-2006. |
| [32] | Kandulski A, Weigt J, Caro C, et al. Esophageal intraluminal baseline impedance differentiates gastroesophageal reflux disease from functional heartburn[J]. Clin Gastroenterol Hepatol, 2015, 13(6):1075-1081. |
/
| 〈 |
|
〉 |
